Literature DB >> 31173856

Akt in cancer: Mediator and more.

Sundaramoorthy Revathidevi1, Arasambattu Kannan Munirajan2.   

Abstract

Akt is a serine/threonine kinase and it participates in the key role of the PI3K signaling pathway. The Akt can be activated by a wide range of growth signals and the biochemical mechanisms leading to Akt activation are well defined. Once activated, Akt modulates the function of many downstream proteins involved in cellular survival, proliferation, migration, metabolism, and angiogenesis. The Akt is a central node of many signaling pathways and it is frequently deregulated in many types of human cancers. In this review, we provide an overview of Akt function and its role in the hallmarks of human cancer. We also discussed various mechanisms of Akt dysregulation in cancers, including epigenetic modifications like methylation, post-transcriptional non-coding RNAs-mediated regulation, and the overexpression and mutation.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Akt; Akt inhibitor; Cancer hallmarks; Mutation; lncRNA; miRNA

Mesh:

Substances:

Year:  2019        PMID: 31173856     DOI: 10.1016/j.semcancer.2019.06.002

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  99 in total

Review 1.  RETRACTED ARTICLE: Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours.

Authors:  Fei Xu; Lixin Na; Yanfei Li; Linjun Chen
Journal:  Cell Biosci       Date:  2020-04-01       Impact factor: 7.133

2.  Identification of an antitumor effect of demethylzeylasteral on human gastric cancer cells.

Authors:  Yang Yang; Menglin Zhao; Ting Hu; Fang Su; Feng Qian; Zishu Wang
Journal:  Oncol Lett       Date:  2020-11-18       Impact factor: 2.967

3.  The pivotal role of glycogen synthase kinase 3 (GSK-3) in vomiting evoked by specific emetogens in the least shrew (Cryptotis parva).

Authors:  W Zhong; N A Darmani
Journal:  Neurochem Int       Date:  2019-11-15       Impact factor: 3.921

4.  Therapeutic Effect of Catgut Implantation at Acupoint in a Mouse Model of Hepatocellular Carcinoma by Suppressing Immune Escape.

Authors:  Shi-Hua Xu; Hao-Xuan Luo; Bi-Jun Huang; Ling Yu; Shao-Ju Luo; Hao Hu; Yan Li; Xiao-Tong Lin; Zhi-Rui Cao; Yuan-Jiang Deng; Shi-Jun Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-08       Impact factor: 2.629

5.  Ortho-silicic Acid Plays a Protective Role in Glucocorticoid-Induced Osteoporosis via the Akt/Bad Signal Pathway In Vitro and In Vivo.

Authors:  Guanghui Gu; Dehui Hou; Guangjun Jiao; Wenliang Wu; Hongming Zhou; Hongliang Wang; Yunzhen Chen
Journal:  Biol Trace Elem Res       Date:  2022-03-21       Impact factor: 3.738

6.  Mechanism of protective effect of carnosol on pig intestinal epithelial cells.

Authors:  Zhiguo Jiang; Li Li; Lianjie Hou; Zhuoqiang Zhou; Chong Wang
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

7.  4Ei-10 interdiction of oncogenic cap-mediated translation as therapy for non-small cell lung cancer.

Authors:  Blake A Jacobson; Zeeshan Ahmad; Sierra Chen; Gabriella Waldusky; Maxwell Dillenburg; Emilia Stoian; Daniel A Cambron; Anil J Patel; Manish R Patel; Carston R Wagner; Robert A Kratzke
Journal:  Invest New Drugs       Date:  2020-11-23       Impact factor: 3.850

Review 8.  Histone deacetylase 10, a potential epigenetic target for therapy.

Authors:  Fajuan Cheng; Bin Zheng; Jianwei Wang; Guiting Zhao; Zhongshun Yao; Zhihong Niu; Wei He
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

9.  Aberrant JmjC domain-containing protein 8 (JMJD8) expression promotes activation of AKT and tumor epithelial-mesenchymal transition.

Authors:  Yao Su; Xueying Wang; Zhen Guo; Jun Wang
Journal:  Oncogene       Date:  2020-09-02       Impact factor: 9.867

10.  SPNS2 Downregulation Induces EMT and Promotes Colorectal Cancer Metastasis via Activating AKT Signaling Pathway.

Authors:  Lei Lv; Qiyi Yi; Ying Yan; Fengmei Chao; Ming Li
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.